What is the new drug for bone loss? An update on Romosozumab, biosimilars, and other treatments
Affecting over 10 million Americans, osteoporosis and subsequent bone loss is a serious health concern that can lead to debilitating fractures. While numerous treatments exist, the question, "What is the new drug for bone loss?" points to recent advancements like Romosozumab (Evenity) and the 2025 introduction of biosimilars for Prolia.